DK0603386T3 - Parenteral immunisering mod rotavirus - Google Patents
Parenteral immunisering mod rotavirusInfo
- Publication number
- DK0603386T3 DK0603386T3 DK93917119T DK93917119T DK0603386T3 DK 0603386 T3 DK0603386 T3 DK 0603386T3 DK 93917119 T DK93917119 T DK 93917119T DK 93917119 T DK93917119 T DK 93917119T DK 0603386 T3 DK0603386 T3 DK 0603386T3
- Authority
- DK
- Denmark
- Prior art keywords
- rotavirus
- immunization against
- parenteral immunization
- against rotavirus
- vaccine
- Prior art date
Links
- 230000003053 immunization Effects 0.000 title abstract 4
- 238000002649 immunization Methods 0.000 title abstract 3
- 241000702670 Rotavirus Species 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 206010067470 Rotavirus infection Diseases 0.000 abstract 1
- 229940124859 Rotavirus vaccine Drugs 0.000 abstract 1
- 229940031551 inactivated vaccine Drugs 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 229940126578 oral vaccine Drugs 0.000 abstract 1
- 229940031626 subunit vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Catalysts (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/911,593 US6780630B1 (en) | 1992-07-10 | 1992-07-10 | Parenteral immunization against rotavirus |
| PCT/US1993/006543 WO1994001134A1 (en) | 1992-07-10 | 1993-07-12 | Parenteral immunization against rotavirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0603386T3 true DK0603386T3 (da) | 2002-03-11 |
Family
ID=25430523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93917119T DK0603386T3 (da) | 1992-07-10 | 1993-07-12 | Parenteral immunisering mod rotavirus |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6780630B1 (da) |
| EP (1) | EP0603386B1 (da) |
| JP (1) | JPH07501558A (da) |
| KR (2) | KR100354587B1 (da) |
| AT (1) | ATE211923T1 (da) |
| AU (1) | AU673370B2 (da) |
| CA (1) | CA2116971A1 (da) |
| DE (1) | DE69331459T2 (da) |
| DK (1) | DK0603386T3 (da) |
| ES (1) | ES2166763T3 (da) |
| IL (1) | IL106306A (da) |
| NO (1) | NO307815B1 (da) |
| PT (1) | PT603386E (da) |
| WO (1) | WO1994001134A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5626851A (en) * | 1987-11-30 | 1997-05-06 | The Wistar Institute Of Anatomy And Biology | Rotavirus reassortant vaccine |
| US6210677B1 (en) * | 1993-01-29 | 2001-04-03 | Robert C. Bohannon | Method to reduce the physiologic effects of drugs on mammals |
| US6673355B1 (en) | 1995-06-14 | 2004-01-06 | Baylor College Of Medicine | Rotavirus enterotoxin NSP4 and methods of using same |
| ATE248601T1 (de) | 1995-06-14 | 2003-09-15 | Baylor College Medicine | Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4 |
| WO2009032913A2 (en) | 2007-09-04 | 2009-03-12 | The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health And Human Services | Thermal inactivation of rotavirus |
| BRPI1007721B1 (pt) | 2009-05-12 | 2020-04-28 | The Government Of The Us Secretary Department Of Health And Human Services Centers For Disease Contr | composição de vacina para uso na indução de uma resposta imunológica contra um rotavírus em um indivíduo, cepa de rotavírus isolado de cdc-9 e cepa de rotavírus isolado de cdc-66 |
| US10532093B2 (en) * | 2014-07-18 | 2020-01-14 | Mds Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2483779A1 (fr) * | 1980-06-05 | 1981-12-11 | Synthelabo | Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins |
| US4341763A (en) * | 1981-03-10 | 1982-07-27 | Smithkline-Rit | Methods of vaccinating humans against rotavirus infection |
| US4636385A (en) * | 1985-02-15 | 1987-01-13 | The Wistar Institute Of Anatomy & Biology | Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection |
| US4861864A (en) * | 1985-05-14 | 1989-08-29 | Albert Einstein College of Medicine of Yeshiva University (a Div. of Yeshiva University) | Rotavirus antigens |
| US4704275A (en) * | 1985-08-26 | 1987-11-03 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against rotavirus diseases |
| EP0251467A3 (en) * | 1986-06-20 | 1988-07-20 | Abbott Laboratories | Compositions and methods of use for a major outer capsid protein (vp7) of rotavirus sa-11 |
| US4927628A (en) * | 1987-09-21 | 1990-05-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against rotavirus diseases and method of preparing same |
| US5147639A (en) * | 1990-06-19 | 1992-09-15 | Ambico, Inc. | Type-c rotavirus cultures and uses therefor |
| ES2121841T3 (es) * | 1990-11-16 | 1998-12-16 | Childrens Hosp Medical Center | Una vacuna para proporcionar proteccion inmunologica contra enfermedades de rotavirus en humanos. |
-
1992
- 1992-07-10 US US07/911,593 patent/US6780630B1/en not_active Expired - Fee Related
-
1993
- 1993-07-12 CA CA002116971A patent/CA2116971A1/en not_active Abandoned
- 1993-07-12 EP EP93917119A patent/EP0603386B1/en not_active Revoked
- 1993-07-12 KR KR1020017006840A patent/KR100354587B1/ko not_active IP Right Cessation
- 1993-07-12 IL IL10630693A patent/IL106306A/en not_active IP Right Cessation
- 1993-07-12 PT PT93917119T patent/PT603386E/pt unknown
- 1993-07-12 AT AT93917119T patent/ATE211923T1/de not_active IP Right Cessation
- 1993-07-12 ES ES93917119T patent/ES2166763T3/es not_active Expired - Lifetime
- 1993-07-12 DK DK93917119T patent/DK0603386T3/da active
- 1993-07-12 DE DE69331459T patent/DE69331459T2/de not_active Expired - Fee Related
- 1993-07-12 AU AU46740/93A patent/AU673370B2/en not_active Ceased
- 1993-07-12 JP JP6503564A patent/JPH07501558A/ja not_active Ceased
- 1993-07-12 KR KR1019940700778A patent/KR940702388A/ko not_active Application Discontinuation
- 1993-07-12 WO PCT/US1993/006543 patent/WO1994001134A1/en not_active Application Discontinuation
-
1994
- 1994-03-09 NO NO940827A patent/NO307815B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0603386A1 (en) | 1994-06-29 |
| DE69331459D1 (de) | 2002-02-21 |
| AU4674093A (en) | 1994-01-31 |
| DE69331459T2 (de) | 2002-06-20 |
| ATE211923T1 (de) | 2002-02-15 |
| AU673370B2 (en) | 1996-11-07 |
| IL106306A (en) | 2002-07-25 |
| CA2116971A1 (en) | 1994-01-20 |
| NO940827L (no) | 1994-05-09 |
| KR100354587B1 (ko) | 2002-10-04 |
| WO1994001134A1 (en) | 1994-01-20 |
| IL106306A0 (en) | 1993-11-15 |
| NO307815B1 (no) | 2000-06-05 |
| US6780630B1 (en) | 2004-08-24 |
| JPH07501558A (ja) | 1995-02-16 |
| PT603386E (pt) | 2002-06-28 |
| KR940702388A (ko) | 1994-08-20 |
| EP0603386B1 (en) | 2002-01-16 |
| NO940827D0 (no) | 1994-03-09 |
| ES2166763T3 (es) | 2002-05-01 |
| EP0603386A4 (en) | 1996-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2588A (da) | Antigen konjugat og fremstilling deraf, samt vaccine indeholdende dette | |
| PL304419A1 (en) | Urease based vaccine against heliobacter infections | |
| ATE242319T1 (de) | Deletionsmutanten als impfstoffe gegen cholera | |
| AU7814498A (en) | Multivalent (in ovo) avian vaccine | |
| ID21338A (id) | Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan | |
| HUP9701586A2 (hu) | Javított inaktivált vakcinák | |
| DK0603386T3 (da) | Parenteral immunisering mod rotavirus | |
| DK0536302T3 (da) | Forbedrede adjuvanser og vacciner | |
| ATE372129T1 (de) | Impfstoff von umhüllten viren und verfahren zu seiner herstellung | |
| Koplan et al. | An update on the benefits and costs of measles and rubella immunization. | |
| MX9301736A (es) | Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1. | |
| NO913131L (no) | Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid. | |
| DK0587636T3 (da) | Fiskevaccine til Aeromonas salmonicida-infektion | |
| GB9303681D0 (en) | Vaccines | |
| AU2579600A (en) | Product and method for obtaining specific immunisation with one or more antigens | |
| RU96123912A (ru) | Способ иммунопрофилактики экспериментальной лепрозной инфекции | |
| RU2000112250A (ru) | Способ сезонной вакцинопрофилактики паротита на крайнем севере | |
| FR2698271B1 (fr) | Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination. |